ADARx Pharmaceuticals, Inc. (ADRX) stock
ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Last filing: 10-Q on Nov 12, 2026
$13.82−0.18 (-1.29%)
Close on Nov 17, 2026Market cap $1.48BP/E –Yield –
ADARx Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
No cash figures for ADARx Pharmaceuticals
ADARx Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?